2 completed, 1 not yet recruiting, 1 recruiting. 3 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Completed 1, Not yet recruiting 1, Recruiting 1 |
| Phase 1 | 1 | Completed 1 |
Follow Schizophrenia Spectrum: new trials by email Literature Review of Schizophrenia Spectrum trials Research Report on Schizophrenia Spectrum
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Safety and Effectiveness of dTMS for Reducing Antipsychotic-induced Weight Gain dTMS of accelerated intermittent theta burst stimulation, ACC-iTBS, Sham stimulation - Schizophrenia Spectrum, Schizophrenia | Not applicable | Recruiting | Second Xiangya Hospital of Central South University | 60 | 2026-11-01 | 2026-10-27 |
| Cost-utility Study of Cognitive-behavioral Management of Auditory Hallucinations in Schizophrenic Disorder Cognitive and behavioral therapy for auditory hallucinations, Usual treatment - Auditory Hallucinations, Schizophrenia Spectrum | Not applicable | Not yet recruiting | University Hospital, Montpellier | 240 | 2025-08-01 | 2025-08-21 |
| Relative Bioavailability of LY03010 Compared to Listed Drug LY03010; paliperidone palmitate, INVEGA SUSTENNA - Schizophrenia, Psychotic Disorders | Phase 1 | Completed | Luye Pharma Group Ltd. | 281 | 2021-01-13 | 2023-04-25 |
| Target Engagement for Oxytocin: Dose Ranging Study Intranasal Oxytocin - Schizophrenia Spectrum | Not applicable | Completed | University of California, Los Angeles | 51 | 2015-09-01 | 2019-01-31 |
Schizophrenia (3) · Psychotic Disorders (2) · Hallucinations (1) · Mental Disorders (1) · Mood Disorders (1)
Schizophrenia Spectrum and Other Psychotic Disorders (3) · Mental Disorders (2) · Nervous System Diseases (1) · Neurobehavioral Manifestations (1) · Neurologic Manifestations (1) · Pathological Conditions, Signs and Symptoms (1) · Perceptual Disorders (1) · Signs and Symptoms (1)
Behavior Therapy (1) · Paliperidone Palmitate (1)
Luye Pharma Group Ltd. (1) · Second Xiangya Hospital of Central South University (1) · University Hospital, Montpellier (1) · University of California, Los Angeles (1)
China (1) · France (1) · United States (1)
Rui Li, MD (1)